Removable Devices in Palatal Expansion

Sponsor
University of L'Aquila (Other)
Overall Status
Completed
CT.gov ID
NCT05848882
Collaborator
(none)
70
1
2
1.3
52

Study Details

Study Description

Brief Summary

The goal of this clinical trial si to compare two removable devices used to treat the transversal discrepancies in growing patients.

The main questions it aims to answer are:
  • the efficacy of the two devices in the palatal expansion

  • the neuromuscolar effects developed on the stomatognatic system Participants will be instructed in the use and maintenance of the devices and will be checked every 15-30 days for one year.

Condition or Disease Intervention/Treatment Phase
  • Device: Elastodontic Device
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
70 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Comparison Between Removable Devices in Palatal Expansion: a Randomized Open Label Clinical Trial
Actual Study Start Date :
Mar 16, 2023
Actual Primary Completion Date :
Apr 18, 2023
Actual Study Completion Date :
Apr 26, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Elastodontic removable device

Patients in this group will be treat with an elastodontic device adapted to the patient according to the shape of the dental arches. This device is similar to a mouthguard and embraces both dental arches. This appliance is worn overnight and the patient will be checked every month. The distance between the palatal cusps of the first upper premolars will be taken at T0( before the start of the therapy), at T1 (after six months)and at T2 (after one month). All the dental recors will be taken by the same operator with an intraoral scanner 3D.

Device: Elastodontic Device
Removable device that embraces two dental archs

Experimental: Schwarz removable device

Patients in this group will be treat with a Schwarz removable device constructed individually by the dental technician.This device has a resin baseplate with an activation screw in the center and Adams hooks on the upper first molars and it works by turning the expansion screw in the center of the palate one-quarter turn, once or twice a month by the ortodontist. This appliance is worn overnight and some hours during the day (totally 16 hours).The distance between the palatal cusps of the first upper premolars will be taken at T0( before the start of the therapy), at T1 (after six months)and at T2 (after one month). All the dental recors will be taken by the same operator with an intraoral scanner 3D.

Device: Elastodontic Device
Removable device that embraces two dental archs

Outcome Measures

Primary Outcome Measures

  1. Palatal first premolars width [12 months]

    To compare the palatal first premolars width in three times

Eligibility Criteria

Criteria

Ages Eligible for Study:
9 Years to 15 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:

skeletal class I relationship, molar class I relationship; complete eruption of upper first premolars ; presence of unilateral or bilateral cross bite (falling within grade 3 IOTN index)

Exclusion Criteria:

IOTN index >4; presence of temporomandibular disorders, epilepsy, systemic diseases, periodontal disease, absence of written informed consent signed by parents/legal guardians

Contacts and Locations

Locations

Site City State Country Postal Code
1 Dipartimento MeSVA L'Aquila Aq Italy 67100

Sponsors and Collaborators

  • University of L'Aquila

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Eleonora Ortu, Principal Investigator, University of L'Aquila
ClinicalTrials.gov Identifier:
NCT05848882
Other Study ID Numbers:
  • IRB L'Aquila 57/2021-2022
First Posted:
May 8, 2023
Last Update Posted:
May 12, 2023
Last Verified:
May 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Eleonora Ortu, Principal Investigator, University of L'Aquila

Study Results

No Results Posted as of May 12, 2023